RedactBio
Lexington, US · Founded 2018 · Delaware corporation
RedactBio is a biotechnology company working at the intersection of gene editing and tissue engineering.
Founders & leadership
GM
Geoff MacKayNamed on SEC filing
CV
Christopher V. GemmitiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2019
▶$500KraisedMay 2019 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMay 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff MacKayExecutive Officer, Director
- Christopher V. GemmitiExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does RedactBio do?
- RedactBio is a biotechnology company working at the intersection of gene editing and tissue engineering.
- How much funding has RedactBio raised?
- RedactBio has disclosed $500K raised across 1 round.
- Where is RedactBio headquartered?
- RedactBio is headquartered in Lexington, US.